INSP is expected to report earnings to fall 14.50% to 11 cents per share on November 09
Q3'26
Est.
$0.12
Q2'26
Beat
by $0.38
Q1'26
Beat
by $0.43
Q4'25
Beat
by $0.97
Q3'25
Beat
by $0.58
The last earnings report on August 03 showed earnings per share of 14 cents, beating the estimate of -23 cents. With 38.51K shares outstanding, the current market capitalization sits at 1.80B.
A.I. Advisor
published General Information
General Information
a developer of implantable neurostimulation systems to treat obstructive sleep apnea
A.I.dvisor indicates that over the last year, INSP has been loosely correlated with VIVO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INSP jumps, then VIVO could also see price increases.
INSP in +3.57% Uptrend, growing for three consecutive days on August 31, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where INSP advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 19, 2026. You may want to consider a long position or call options on INSP as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 198 cases where INSP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for INSP moved out of overbought territory on August 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where INSP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for INSP turned negative on August 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INSP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
INSP broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INSP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.176) is normal, around the industry mean (10.896). P/E Ratio (13.717) is within average values for comparable stocks, (69.723). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.709). INSP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (2.028) is also within normal values, averaging (36.318).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Inspire Medical Systems (INSP) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com
